A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding

95Citations
Citations of this article
249Readers
Mendeley users who have this article in their library.

Abstract

We have adapted an in vitro model of the human blood-brain barrier, the immortalized human cerebral microvascular endothelial cells (hCMEC/D3), to quantitatively measure protein transcytosis. After validating the receptor-mediated transport using transferrin, the system was used to measure transcytosis rates of antibodies directed against potential brain shuttle receptors. While an antibody to the insulin-like growth factor 1 receptor (IGF1R) was exclusively recycled to the apical compartment, the fate of antibodies to the transferrin receptor (TfR) was determined by their relative affinities at extracellular and endosomal pH. An antibody with reduced affinity at pH5.5 showed significant transcytosis, while pHindependent antibodies of comparable affinities at pH 7.4 remained associated with intracellular vesicular compartments and were finally targeted for degradation. © 2014 Sade et al.

Cite

CITATION STYLE

APA

Sade, H., Baumgartner, C., Hugenmatter, A., Moessner, E., Freskgård, P. O., & Niewoehner, J. (2014). A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding. PLoS ONE, 9(4). https://doi.org/10.1371/journal.pone.0096340

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free